X Corp.
Search results
Neuralink is a company that aims to create a generalized brain interface to restore autonomy to those with unmet medical needs and unlock human potential. Learn about their mission, potential impact, approach, and how to join their patient registry or explore their careers.
- Mailing List
Subscribe to Neuralink to receive the latest updates and...
- Series C Funding Round Announcement
Neuralink has spent the last four years developing the first...
- Neuralink's Approach to Animal Welfare
At Neuralink, we are absolutely committed to working with...
- Championing The 3 Rs
The “3 Rs alternatives” refers to the refinement, reduction,...
- Mailing List
t. e. Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs), and is based in Fremont, California. Founded by Elon Musk and a team of seven scientists and engineers, Neuralink was launched in 2016 and was first publicly reported in March 2017.
Jan 30, 2024 · Bill Chappell. Enlarge this image. Neuralink has conducted its first surgical test of a brain implant, Elon Musk says. An example of the device, whose size has been compared to a coin and which...
May 9, 2024 · Neuralink is a neurotechnology company that aims to decode and stimulate brain activity with a surgically implanted chip. Learn about the technology, its potential uses, its FDA status and its ethical challenges.
May 26, 2023 · Elon Musk's Neuralink received U.S. Food and Drug Administration (FDA) clearance for its first-in-human clinical trial, a critical milestone for the brain-implant startup as it faces U.S. probes...
May 26, 2023 · By James FitzGerald,BBC News. Reuters. Elon Musk's brain-chip firm says it has received approval from the US Food and Drugs Administration (FDA) to conduct its first tests on humans. The...
Jan 30, 2024 · Elon Musk's brain science start-up Neuralink has announced the successful implantation of a device in a human for the first time. The company aims to enable computer control by thinking, but faces federal investigations and skepticism from neuroscientists.
